SBI Securities
VTVT icon

SBI Securities’s vTv Therapeutics VTVT Stock Holding History

SBI Securities’s Portfolio VTVT Stock Details VTVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$62 Hold
2
– – ﹤0.01% 3689
2026
Q2 		$75 Hold
2
– – ﹤0.01% 3578
2026
Q1 		$79 Hold
2
– – ﹤0.01% 3470
2025
Q4 		$80 Hold
2
– – ﹤0.01% 3474
2025
Q3 		$47 Hold
2
– – ﹤0.01% 3742
2025
Q2 		$30 Sell
2
-8
-80% -$147 ﹤0.01% 3831
2025
Q1 		$173 Buy
+10
New +$167 ﹤0.01% 3271

Other funds holding VTVT

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
China Universal Asset Management Company
China Universal Asset Management Company Shanghai, China $1.92B AUM 74.14% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
Strengthening Families & Communities LLC
Strengthening Families & Communities LLC Boston, Massachusetts $459M AUM 29.64% 1-Year Est. Return
State of Wyoming
State of Wyoming Cheyenne, Wyoming $1.29B AUM 32.25% 1-Year Est. Return
Activest Wealth Management
Activest Wealth Management Aventure, Florida $540M AUM 34.92% 1-Year Est. Return
CoreCap Advisors
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return
Parallel Advisors
Parallel Advisors San Francisco, California $7.42B AUM 27.68% 1-Year Est. Return
Caitong International Asset Management
Caitong International Asset Management Hong Kong $1.04B AUM 150.26% 1-Year Est. Return

SBI Securities's VTVT Position: Q3 2026 in Review

SBI Securities held its vTv Therapeutics (VTVT) position steady in Q3 2026 at 2 shares worth $62. The position accounts for ﹤0.01% of the portfolio, ranked #3689.

SBI Securities first reported a position in VTVT in Q1 2025 and has held it in 7 quarters since. The position peaked at $173 in Q1 2025. 11 funds tracked by Wall St. Rank hold VTVT as of Q3 2026.

  • SBI Securities held 2 shares of vTv Therapeutics worth $62 as of Q3 2026.
  • SBI Securities left its vTv Therapeutics share count unchanged in Q3 2026.
  • vTv Therapeutics made up ﹤0.01% of SBI Securities's portfolio in Q3 2026, its #3689 holding.
  • SBI Securities first reported a position in vTv Therapeutics in Q1 2025 and has held it in 7 quarters since.
  • SBI Securities's vTv Therapeutics position peaked at $173 in Q1 2025.
  • 11 funds tracked by Wall St. Rank held vTv Therapeutics as of Q3 2026.

Based on SBI Securities's 13F filing for Q3 2026, filed 22 Oct 2026.